Found: 52
Select item for more details and to access through your institution.
The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical & Translational Gastroenterology, 2017, v. 8, n. 1, p. e217, doi. 10.1038/ctg.2016.72
- By:
- Publication type:
- Article
Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96966-5
- By:
- Publication type:
- Article
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. e1542, doi. 10.1210/clinem/dgad375
- By:
- Publication type:
- Article
The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/ Obesity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. e3624, doi. 10.1210/clinem/dgac405
- By:
- Publication type:
- Article
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. e520, doi. 10.1210/clinem/dgaa792
- By:
- Publication type:
- Article
Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
- Published in:
- Liver International, 2011, v. 31, n. 3, p. 330, doi. 10.1111/j.1478-3231.2010.02332.x
- By:
- Publication type:
- Article
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.
- Published in:
- Liver International, 2009, v. 29, n. 5, p. 748, doi. 10.1111/j.1478-3231.2009.01973.x
- By:
- Publication type:
- Article
Transgender Women with HIV Demonstrate Unique Non-Alcoholic Fatty Liver Disease Profiles.
- Published in:
- Transgender Health, 2024, v. 9, n. 5, p. 413, doi. 10.1089/trgh.2022.0182
- By:
- Publication type:
- Article
Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 5, p. 666, doi. 10.1111/apt.17849
- By:
- Publication type:
- Article
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 513, doi. 10.1111/apt.15830
- By:
- Publication type:
- Article
Biomass fuel as a risk factor for esophageal squamous cell carcinoma: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.
- Published in:
- Scientific Reports, 2015, p. 18277, doi. 10.1038/srep18277
- By:
- Publication type:
- Article
Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114747
- By:
- Publication type:
- Article
The Absence of Obstructive Sleep Apnea May Protect against Non-Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062504
- By:
- Publication type:
- Article
Serum Vitamin D Levels Are Not Predictive of the Progression of Chronic Liver Disease in Hepatitis C Patients with Advanced Fibrosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0027144
- By:
- Publication type:
- Article
Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2230426, doi. 10.1001/jamanetworkopen.2022.30426
- By:
- Publication type:
- Article
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 11, p. 920, doi. 10.1001/jama.2024.1215
- By:
- Publication type:
- Article
MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02317-4
- By:
- Publication type:
- Article
Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 2, p. e190047, doi. 10.1001/jamanetworkopen.2019.0047
- By:
- Publication type:
- Article
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 621, doi. 10.1093/cid/ciab019
- By:
- Publication type:
- Article
Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. 2087, doi. 10.1093/cid/ciaa382
- By:
- Publication type:
- Article
Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Erratum to: A Randomized Controlled Trial of Double Versus Triple Therapy with Amantadine for Genotype 1 Chronic Hepatitis C in Latino Patients.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.
- Published in:
- Lipids in Health & Disease, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-511X-13-100
- By:
- Publication type:
- Article
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89966-y
- By:
- Publication type:
- Article
Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
- Published in:
- Current HIV/AIDS Reports, 2018, v. 15, n. 3, p. 212, doi. 10.1007/s11904-018-0392-1
- By:
- Publication type:
- Article
Improvement in Liver Histology Is Associated With Reduction in Dyslipidemia in Children With Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2015, v. 60, n. 3, p. 360, doi. 10.1097/MPG.0000000000000584
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.
- Published in:
- PLoS ONE, 2023, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0279685
- By:
- Publication type:
- Article
Plasma Free Cortisol in States of Normal and Altered Binding Globulins: Implications for Adrenal Insufficiency Diagnosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
- Published in:
- Clinical Transplantation, 2016, v. 30, n. 4, p. 452, doi. 10.1111/ctr.12710
- By:
- Publication type:
- Article
Editorial: re‐thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 988, doi. 10.1111/apt.15696
- By:
- Publication type:
- Article
Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 728, doi. 10.1111/apt.15660
- By:
- Publication type:
- Article
Relationship between resolution of non‐alcoholic steatohepatitis and changes in lipoprotein sub‐fractions: a post‐hoc analysis of the PIVENS trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1205, doi. 10.1111/apt.15216
- By:
- Publication type:
- Article
Secondary causes of nonalcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2012, v. 5, n. 3, p. 199, doi. 10.1177/1756283X11430859
- By:
- Publication type:
- Article
Review: Current status of therapy for hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Gastroenterology, 2009, v. 2, n. 1, p. 45, doi. 10.1177/1756283X08100328
- By:
- Publication type:
- Article
Proteomic Analysis of Hepatic Fibrosis in HIV-Associated NAFLD Demonstrates Upregulation of Immune Response and Tissue Repair Pathways.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community‐Based Cohort.
- Published in:
- Obesity (19307381), 2021, v. 29, n. 3, p. 595, doi. 10.1002/oby.23100
- By:
- Publication type:
- Article
Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction.
- Published in:
- 2017
- By:
- Publication type:
- journal article